C204-0107 Screening compound: N'-{3-[4-(3-chlorophenyl)piperazin-1-yl]propyl}-N-[4-methyl-2-(morpholin-4-yl)quinolin-6-yl]butanediamide

C204-0107 Screening compound: N'-{3-[4-(3-chlorophenyl)piperazin-1-yl]propyl}-N-[4-methyl-2-(morpholin-4-yl)quinolin-6-yl]butanediamide
C204-0107 Screening compound: N'-{3-[4-(3-chlorophenyl)piperazin-1-yl]propyl}-N-[4-methyl-2-(morpholin-4-yl)quinolin-6-yl]butanediamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C204-0107
N'-{3-[4-(3-chlorophenyl)piperazin-1-yl]propyl}-N-[4-methyl-2-(morpholin-4-yl)quinolin-6-yl]butanediamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C204-0107

Molecular Formula

C31H39ClN6O3 (C31 H39 ClN6 O3)

Compound Name

N'-{3-[4-(3-chlorophenyl)piperazin-1-yl]propyl}-N-[4-methyl-2-(morpholin-4-yl)quinolin-6-yl]butanediamide

IUPAC name

N'-{3-[4-(3-chlorophenyl)piperazin-1-yl]propyl}-N-[4-methyl-2-(morpholin-4-yl)quinolin-6-yl]butanediamide

SMILES

Cc1c(cc(cc2)NC(CCC(NCCCN(CC3)CCN3c3cccc(Cl)c3)=O)=O)c2nc(N2CCOCC2)c1

InChI

InChI=1S/C31H39ClN6O3/c1-23-20-29(38-16-18-41-19-17-38)35-28-7-6-25(22-27(23)28)34-31(40)9-8-30(39)33-10-3-11-36-12-14-37(15-13-36)26-5-2-4-24(32)21-26/h2,4-7,20-22H,3,8-19H2,1H3,(H,33,39)(H,34,40)

InChI Key

FMKFPAZJTOSHQP-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14731964

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

579.14

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

12.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

3.679

Distribution Coefficient, logD

3.093

Water Solubility, LogSw

-3.89

Polar Surface Area

73.827

Acid Dissociation Constant (pKa)

11.10

Base Dissociation Constant (pKb)

7.86

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

45.20

C204-0107 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Lipid Metabolism Library (9174 compounds)

PI3K-Targeted Library (17255 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cardiovascular
  • Metabolic
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • GPCR
  • Kinases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with C204-0107 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C204-0107?
Check Price and Availability of C204-0107, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C204-0107 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C204-0107
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C204-0107
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C204-0107 available by request